Glucocorticoids suppress renal cell carcinoma progression by enhancing Na, K-ATPase beta-1 subunit expression

PLoS ONE

Volumn 10, Issue 4, 2015, Pages

  Huynh, Thu P ^a,b   Barwe, Sonali P ^b   Lee, Seung J ^b   McSpadden, Ryan ^b   Franco, Omar E ^c   Hayward, Simon W ^c   Damoiseaux, Robert ^a   Grubbs, Stephen S ^d   Petrelli, Nicholas J ^d   Rajasekaran, Ayyappan K ^d,e,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c VANDERBILT UNIVERSITY   (United States)

^d HELEN F GRAHAM CANCER CENTER   (United States)

^e UNIVERSITY OF DELAWARE   (United States)

^f Therapy Architects   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; DEXAMETHASONE; FLUOROMETHOLONE; SODIUM POTASSIUM ATPASE BETA SUBUNIT ISOFORM 1; TRIAMCINOLONE; UNCLASSIFIED DRUG; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ATP1B1 PROTEIN, HUMAN; GLUCOCORTICOID; MESSENGER RNA; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL AGGREGATION; CELL SURFACE; CONTROLLED STUDY; DOWN REGULATION; DRUG STRUCTURE; EPITHELIAL MESENCHYMAL TRANSITION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; MALE; MOUSE; NONHUMAN; UPREGULATION; ANIMAL; CARCINOMA, RENAL CELL; DISEASE COURSE; DRUG EFFECTS; DRUG SCREENING; ENZYMOLOGY; GENETICS; HAIRLESS MOUSE; HELA CELL LINE; KIDNEY NEOPLASMS; METABOLISM; PATHOLOGY; PREVENTION AND CONTROL; PROMOTER REGION; SCID MOUSE; TUMOR CELL LINE; TUMOR INVASION;

ANIMALS; CARCINOMA, RENAL CELL; CELL ADHESION; CELL LINE, TUMOR; DEXAMETHASONE; DISEASE PROGRESSION; FLUOROMETHOLONE; GLUCOCORTICOIDS; HELA CELLS; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; MICE, HAIRLESS; MICE, SCID; NEOPLASM INVASIVENESS; PROMOTER REGIONS, GENETIC; RNA, MESSENGER; RNA, NEOPLASM; SODIUM-POTASSIUM-EXCHANGING ATPASE; TRIAMCINOLONE; UP-REGULATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84926622710     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0122442     Document Type: Article

References (50)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59(4):225-49. doi: 10.3322/caac.20006 PubMed PMID: 19474385.
2. Eble JN, Sauter G, Epstein JI, Sesterhenn IA. Pathology and genetics of tumours of the urinary system and male genital organs. Lyon: IARC press; 2004.
3. Murphy AM, Buck AM, Benson MC, McKiernan JM. Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology. 2009;73(6):1293-7. doi: 10.1016/j.urology.2008.12.072 PubMed PMID: 19371933.
4. Reeves DJ, Liu CY. Treatment of metastatic renal cell carcinoma. Cancer Chemother Pharmacol. 2009;64(1):11-25. doi: 10.1007/s00280-009-0983-z PubMed PMID: 19343348.
5. Therein AG, Blostein R. Mechanisms of sodium pump regulation. Am J Physiol Cell Physiol. 2000;279:C541-C66. PMID: 10942705
6. Rajasekaran SA, Ball WJ, Bander NH, Liu H, Pardee JD, Rajasekaran AK. Reduced expression of B-subunitof Na, K-ATPase in human clear-cell renal cell carcinoma. J Urol. 1999;162:574-80. PMID: 10411090
7. Avila J, Leucona E, Morales M, Soriano A, Alonso T, Martin-Vasallo P. Opposite expression pattern of the human Na, K-ATPase B1 isoform in stomach and colon adenocarcinomas. Ann NY Acad Sci. 1997;834(1):653-5.
8. Espineda CE, Seligson DB, Ball WJ, Rao J, Paoltie A, Horvath S, et al. Analysis of the Na, K-ATPase alpha and beta-subunit expression profiles of bladder cancer using tissue microarrays. Cancer. 2003;97(8):1859-68. PMID: 12673711
9. Espineda CE, Chang JH, Twiss J, Rajasekaran SA, Rajasekaran AK. Repression of Na, K-ATPase beta1-subunit by the transcription factor snail in carcinoma. Mol Biol Cell. 2004;15(3):1364-73. doi: 10. 1091/mbc. E03-09-0646 PubMed PMID: 14699059; PubMed Central PMCID: PMC363145.
10. Bab-Dinitz E, Albeck S, Peleg Y, Brumfeld V, Gottschalk KE, Karlish SJD. AC-terminal lobe of the B-subunit of Na, K-ATPaseand H, K-ATPase resembles cell adhesion molecules. Biochemistry. 2009;48:8684-91. doi: 10.1021/bi900868e PMID: 19694409
11. Barwe SP, Kim S., Rajasekarna S. A., Bowie J. U., and Rajasekaran A. K. Janus model of the Na, K-ATPase B-subunit transmembrane domain: distinct faces mediate alpha/beta assembly and beta-beta homo-oligomerization. JMB. 2007;365:706-14. PMID: 17078968
12. Inge LJ, Rajasekaran SA, Yoshimoto K, Mischel PS, McBride W, Landaw E, et al. Evidence for a potential tumor suppressor role for the Na, K-ATPase B-subunit. Histol Histopathol. 2008;23:459-67. PMID: 18228203
13. Kitamura N, Ikekita M, Sato T, Akimoto Y, Hatanaka Y, Kawakami H, et al. Mouse Na, K-ATPase B1-subunit has a K dependent cell adhesion activity for B-glcNAc-terminating glycans. PNAS. 2005;102(8):2796-801. PMID: 15705719
14. Rajasekaran SA, Palmer L. G., Quan K., Harper J. F., Ball W. J., Bander N. H., Peralta Soler A., and Rajasekaran A. K. Na, K-ATPase B-subunit is required for epithelial polarization, suppression of invasion, and cell motility. Mol Cell Biol. 2001b; 12:279-95.
15. Shoshani L, Contreras RG, Roldan ML, Moreno J, Lazaro A, Balda MS, et al. The polarized expression of Na, K-ATPase in epithelia depends on the association between B-subunits located in neighboring cells. Mol Biol Cell. 2005;16:1071-81. PMID: 15616198
16. Vagin O, Tokhtaeva E, Sachs G. The role of B-subunit of the Na, K-ATPaseanditsglycosylation in cellcell adhesion. J BiolChem. 2006;281(51):39573-87. PMID: 17052981
17. Rajasekaran SA, Palmer L. G., Soon S. Y., Peralta Soler, A., Apodaca G. L, Harper J. F., Zheng Y., and Rajasekaran A. K. Na, K-ATPase activity is required for formation of tight junctions, desmosomes, and induction of polarity in eptihelial cells. Mol Biol Cell. 2001a; 12(12):3717-32. PMID: 11739775
18. Rajasekaran SA, Huynh T. P., Wolle D. G., Espineda CE., Inge L. J., Skay A., Lassman C, Nicholas S. B., Harper J. F., Reeves A. E., Ahmed M. M., Leatherman J. M., Mullin J. M., and Rajasekaran A. K. Na, K-ATPase subunits as markers for epithelial-mesenchymal transition in cancer and fibrosis. Mol Cancer Ther. 2010;9(6):1515-24. doi: 10.1158/1535-7163. MCT-09-0832 PMID: 20501797
19. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57-70 PubMed PMID: 10647931.
20. Selvakumar P, Owens TA, David JM, Petrelli NJ, Christensen BC, Lakshmikuttyamma A, et al. Epigenetic silencing of Na, K-ATPase beta 1 subunitgeneATP1B1 by methylation in clear cell renal cell carcinoma. Epigenetics: official journal of the DNA Methylation Society. 2014;9(4):579-86. doi: 10.4161/epi.27795 PubMed PMID: 24452105; PubMed Central PMCID: PMC4121368.
21. Baylin SB, Ohm JE. Epigenetic gene silencing in cancer-a mechanism for early oncogenic pathway addiction? Nature reviews Cancer. 2006;6(2):107-16. doi: 10.1038/nrc1799 PubMed PMID: 16491070.
22. Barwe SP, Anilkumar G, Moon SY, Zheng Y, Whitelegge JP, Rajasekaran SA, et al. A novel role for Na, K-ATPase in phosphatidylinositol 3-kinase signaling and suppresion of cell motility. Mol Biol Cell. 2005;16:1082-94. PMID: 15616195
23. Gorospe M, Egan JM, Zbar B, Lerman M, Geil L, Kuzmin I, et al. Protective function of von Hippel-Lindau protein against impaired protein processing in renal carcinoma cells. Mol Cell Biol. 1999;19(2):1289-300 PubMed PMID: 9891063; PubMed Central PMCID: PMC116058.
24. Barwe SP, Skay A, McSpadden R, Huynh TP, Langhans SA, Inge LJ, et al. Na, K-ATPase beta-subunit cis homo-oligomerization is necessary for epithelial lumen formation in mammalian cells. Journal of cell science. 2012;125(Pt23):5711-20. Epub 2012/10/19. doi: 10.1242/jcs. 108795 PubMed PMID: 23077177; PubMed Central PMCID: PMC3575706.
25. Abbott A, Ball WJ Jr. The epitope for the inhibitor antibody M7-PB-E9 contains Ser-646 and Asp-652 of sheep Na, K-ATPasealpha-subunit. Biochemistry. 1993;32(13):3511-8. PMID: 7681692
26. Sun Y, Ball WJ Jr. Determination of Na (+)-K (+)-ATPase alpha- and beta-isoforms and kinetic properties in mammalian liver. Am J Physiol. 1992;262(6 Pt 1):C1491-9 PubMed PMID: 1319675.
27. Hayward SW, Haughney PC, Lopes ES, Danielpour D, Cunha GR. The rat prostatic epithelial cell line NRP-152 can differentiate in vivo in response to its stromal environment. The Prostate. 1999;39(3):205-12. Epub 1999/05/20 PubMed PMID: 10334110.
28. Hayward SW, Haughney PC, Rosen MA, Greulich KM, Weier HU, Dahiya R, et al. Interactions between adult human prostatic epithelium and rat urogenital sinus mesenchyme in a tissue recombination model. Differentiation; research in biological diversity. 1998;63(3):131-40. Epub 1998/08/11. doi: 10. 1046/j.1432-0436.1998.6330131.x PubMed PMID: 9697307.
29. De Moe JH, Santaguida S, Daum JR, Musacchio A, Gorbsky GJ. A high throughput, whole cell screen for small molecule inhibitors of the mitotic spindle checkpoint identifies OM137, a novel Aurora kinase inhibitor. Cancer Res. 2009;69(4):1509-16. doi: 10.1158/0008-5472. CAN-08-3133 PubMed PMID: 19190331; PubMed Central PMCID: PMC2655231.
30. Kamata K, Wu RP, An DS, Saxe JP, Damoiseaux R, Phelps ME, et al. Cell-based chemical genetic screen identifies damnacanthal as an inhibitor of HIV-1 Vpr induced cell death. Biochem Biophys Res Commun. 2006;348(3):1101-6. PMID: 16904642
31. Zhang Q, Feng W, Zhou H, Yan B. Advances in preclinical small molecules for the treatment of NSCLC. Expert OpinTher Pat. 2009;19(6):731-51. doi: 10.1517/13543770902967674 PubMed PMID: 19456275.
32. Siemann DW, Brazelle WD, Jurgensmeier JM. The vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor cediranib (Recentin; AZD2171) inhibits endothelial cell function and growth of human renal tumor xenografts. Int J Radiat Oncol Biol Phys. 2009;73(3):897-903. doi: 10.1016/j. ijrobp. 2008.10.031 PubMed PMID: 19215823; PubMed Central PMCID: PMC2788500.
33. Xu J, Kochanek KD, Tejada-Vera B. Deaths: preliminary data for 2007. National vital statistics reports [Internet]. 2009;58 (1).
34. Brady ME, Sartiano GP, Rosenblum SL, Zaglama NE, Bauguess CT. The pharmacokinetics of single high doses of dexamethasone in cancer patients. Eur J Clin Pharmacol. 1987;32(6):593-6 PubMed PMID: 3653229.
35. Gassler N, Zhang C, Wenger T, Schnabel PA, Dienemann H, Debatin KM, et al. Dexamethasone-induced cisplatin and gemcitabine resistance in lung carcinoma samples treated ex vivo. Br J Cancer. 2005;92(6):1084-8. doi: 10.1038/sj.bjc.6602453 PubMed PMID: 15756274; PubMed Central PMCID: PMC2361940.
36. Auphan N, Di Donato JA, Rosette C, Helmberg A, Karin M. Immunosuppression by glucocorticoids: inhibition of NF-kappaB activity through induction of I kappa B synthesis. Science. 1995;270 (286-290). PMID: 7569976
37. Barwe SP, Rajasekaran S. A., and Rajasekaran A. K. Identification of protein kinase C as an intermediate in Na, K-ATPase B-subunit mediated lamellipodiaformation and suppression of cell motility in carcinoma cells. Cell Mol Biol. 2006;52(8):41-7. PMID: 17535735
38. Chalaka S, Ingbar DH, Sharma R, Zhau Z, Wendt CH. Na (+)-K (+)-ATPase gene regulation by glucocorticoids in a fetal lung epithelial cell line. Am J Physiol. 1999;277(1 Pt1):L197-203 PubMed PMID: 10409248.
39. Derfoul A, Robertson NM, Lingrel JB, Hall DJ, Litwach G. Regulation of the human Na, K-ATPase beta1 gene promoter by mineralcorticoid and glucocorticoid receptors. J Biol Chem. 1998;273(33):20702-11. PMID: 9694812
40. Hao H, Wendt CH, Sandhu G, Ingbar DH. Dexamethasone stimulates transcription of the Na, K-ATPase B1 gene in rat lung epithelial cels. Am J Physiol Lung Cell Mol Physiol. 2003a; 285:L593-L601. PMID: 12754184
41. Hao H, Rhodes R., Ingbar D. H., and Wendt CH. Dexamethasone responsive element in the rat Na, K-ATPase B1 gene coding region. BiochimicaetBiophysicaActa. 2003b; 1630:55-63. PMID: 14654235
42. Arai Y, Nonomura N, Nakai Y, Nishimura K, Oka D, Shiba M, et al. The growth-inhibitory effects of dexamethasone on renal cell carcinoma in vivo and in vitro. Cancer Invest. 2008;26(1):35-40. Epub 2008/01/09. doi: 10.1080/07357900701638418 PubMed PMID: 18181043.
43. Tummala R, Wolle D, Barwe SP, Sampson VB, Rajasekaran AK, Pendyala L. Expression of Na, K-ATPase-beta1 subunit increases uptake and sensitizes carcinoma cells to oxaliplatin. Cancer Chemother Pharmacol. 2009;64(6):1187-94. doi: 10.1007/s00280-009-0985-x PMID: 19322565
44. Aapro MS, Alberts DS, Serokman R. Lack of dexamethasone effect on the antitumor activity of cisplatin. CancerTreat Rep. 1983;67(11):1013-7 PubMed PMID: 6685569.
45. Yu WD, McElwain MC, Modzelewski RA, Russell DM, Smith DC, Trump DL, et al. Enhancement of 1, 25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst. 1998;90(2):134-41 PubMed PMID: 9450573.
46. Arafa HM, Abdel-Hamid MA, El-Khouly AA, Elmazar MM, Osman AM. Enhancement by dexamethasone of the therapeutic benefits of cisplatin via regulation of tumor angiogenesis and cell cycle kinetics in a murine tumor paradigm. Toxicology. 2006;222(1-2):103-13. doi: 10.1016/j.tox.2006.02.007 PubMed PMID: 16567030.
47. Wang H, Li M, Rinehart JJ, Zhang R. Pretreatmentwith dexamethasone increases antitumor activity of carboplatin and gemcitabine in mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy. Clin Cancer Res. 2004;10(5):1633-44 PubMed PMID: 15014014.
48. Piette C, Deprez M, Roger T, Noel A, Foidart JM, Munaut C. The dexamethasone-induced inhibition of proliferation, migration, and invasion in glioma cell lines is antagonized by macrophage migration inhibitor factor (MIF) and can be enhanced by specific MIF inhibitors. J Biol Chem. 2009;284(47):32483-92. doi: 10.1074/jbc. M109.014589 PMID: 19759012
49. Zhang L, Lei W, Wang X, Tang Y, Song J. Glucocorticoid induces mesenchymal-to-epithelial transition and inhibits TGF-beta1-induced epithelial-to-mesenchymal transition and cell migration. FEBS letters. 2010;584(22):4646-54. Epub 2010/10/26. doi: 10.1016/j.febslet.2010.10.038 PubMed PMID: 20971111.
50. Jang YH, Shin HS, Sun Choi H, Ryu ES, Jin Kim M, Ki Min S, et al. Effects of dexamethasone on the TGF-beta1-induced epithelial-to-mesenchymal transition in human peritoneal mesothelial cells. Laboratory investigation; ajournal of technical methods and pathology. 2013;93(2):194-206. Epub 2012/12/05. doi: 10.1038/labinvest.2012.166 PubMed PMID: 23207448.